Medicare Still Won’t Pay for Hearing Aids, Pricing Hits $7K
Hearing aid costs top $7,000 for mid-range devices, and Original Medicare offers no coverage. The gap is reshaping se...
Flat index levels can mask underlying shifts among components; still, broader market movements may occur through price changes in parts.
28,641 articlesHearing aid costs top $7,000 for mid-range devices, and Original Medicare offers no coverage. The gap is reshaping se...
A timely tribute to Ted Turner and the daring moves that built a media empire. From billboard prince to cable mogul, ...
Investors chasing high monthly yields through the tech-heavy ULTY ETF are wagering on option income to boost income, ...
A Washington retiree fell for a polished gold-coin scam, losing six figures and facing an IRMAA Medicare premium surp...
Banking, housing finance groups urge federal regulators to tailor Basel III capital rules, arguing that overlap and h...
SpaceX is hovering around its $135 IPO price as investors digest post-debut dynamics. One broker, Raymond James, argu...
A new milestone for obesity treatment arrives as Novo Nordisk's Wegovy Pill hits 3 million prescriptions. This articl...
Carson City, Nevada, is drawing attention as the most underrated retirement town for skiers, combining mountain acces...
NWN’s Q1 2026 results reveal how the company balances growth with profitability. This analysis breaks down the number...
Cathie Wood’s approach to downturns leans into disciplined bargain hunting. This article breaks down the idea of cath...
The AI boom isn’t over yet, according to seasoned investor Paul Tudor Jones Says. This piece breaks down why the rall...
A fresh analysis tests whether a $10,000 crypto investment can turn into $1 million by 2030, focusing on BTC, ETH, XR...